Immunocytochemical methods were used to compare the GABA system in control mice and two mutant strains: spastic which has reduced glycine receptors and retinal degeneration mutan'l in which the photoreceptors degenerate and reportedly have increased GABA and GAD levels. We found that the spastic mutant retina had reduced GABA-immunoreactivity (IR) in the proximal retina, reduced staining for GAD-1440 in the OPL, and reduced GABAA receptor staining in the OPL, compared to control. The retinal degeneration mutant retinas had enhanced GABA-IR throughout the retina, particularly in Miiller cells, bipolar cells and IPL, and enhancement of GABAA receptor staining in the OPL, compared to control. The distributions of GABA-IR, GAD-1440-IR and GABAA receptor-IR in retinas of spastic mutant mice that also expressed the re~Fnal degeneration phenotype resembled those found in retinas of mice that expressed only the re~!nal degeneration phenotype rather than those that expressed only the spastic mutation. No differences were observed among the conditions for GAD-65, GAD-67 or GABA-T. Our results with the spastic and retinal degeneration mutant mice demonstrate that attenuation in the glycinergic system and photoreceptor degeneration, respectively, is accompanied by alterations in different aspects of the GABA system, giving impetus for caution in the interpretation of experiments involving genetic manipulation of complex phenotypes. © 1997 Elsevier Science Ltd
INTRODUCTION
Since the identification of y-aminobutyric acid (GABA) in brain tissue by Roberts and Frankel (1950) , GABA has been established as the major inhibitory neurotransmitter in the central nervous system (Mandel & DeFeudis, 1979) including the retina (Yazulla, 1986) . GABA is a transmitter of numerous subtypes of amacrine cell in all species so far investigated and, depending on tile species, GABA is used by subtypes of horizontal cell, interplexiform cell, bipolar cell, or ganglion cell (Marc, 1992; Yazulla, 1986 for reviews). Among mammals, the mouse is used extensively in genetic research and numerous mutations affecting the nervous system, including the retina, have been identified. However, unlike the retinas of primate, cat, rabbit and rat, relatively much less is known about the anatomical distribution of neurotransmitter systems in the mouse retina; some information is available regarding GABA, dopamine and glycine *To whom all correspondence should be addressed neurons in mouse retina (Ballesta et al., 1984; Blanks & Roffler-Tarlov, 1982; Brandon, 1985; Kato et al., 1981; Pinto et al., 1994; Schnitzer & Rusoff, 1984; Wulle & Schnitzer, 1989) . Here, we have focussed on the GABA system of the normal, wild-type mouse and two strains of mice that have visual deficits that result from separate mutations. The first of these mutations, spastic, is recessive and results from the aberrant splicing of the #-subunit of the glycine receptor, encoded by a gene on mouse chromosome 3 (Mtilhardt et al., 1994) . The spastic mutation causes reduced levels of glycine receptors in the central nervous system of homozygotes (Becker, 1990; Becker & Hoch, 1991; Pinto et al., 1994; White & Heller, 1982) . The mutation produces a syndrome similar to human hyperekplexia (Becket & Hoch, 1991) and is accompanied by an 80% reduction, but with no change in affinity, of [3H]strychnine binding in mouse spinal cord (Becker et al., 1986) . The visual consequences of the spastic mutation are seen in ganglion cells in which abnormalities in both spatial and temporal aspects of the responses to light are observed (Stone & Pinto, 1992) . Pinto et al. (1994) observed a significant reduction in the glycine-receptor immunolabeling of both the e and # subunits of the glycine receptor as well as the 93 kDa 3471 3472 s. YAZULLA et al.
cytoplasmic receptor associated protein, gephyrin. As upregulation of GABA receptors has been reported in other areas of the central nervous system (CNS) of the spastic mutant mouse (White & Heller, 1982) , we investigated whether compensatory changes might be found in the retinal GABA system.
The spastic mutation is deleterious to the organism; male homozygous mutants rarely breed, though they have fertile sperm. Thus, the mutation is maintained using a "hybrid inbred" line resulting from a cross between C57BL/6J mice, with normal retinas, and C3H/Fe mice, every one of which is homozygous for the retinal degeneration mutation, found on chromosome 5. As the two genes are unlinked, one-fourth of all animals born, including the spastic mutants, will have the retinal degeneration phenotype. Retinal degeneration mutant mice, with degeneration of photoreceptors and their synaptic contacts (i.e. Sonohara & Shiose, 1968; Caley et al., 1972; Blanks et al., 1974) have few other changes in retinal histology, but have an altered GABAergic system in the retina. Grafstein et al. (1972) reported a 20% decrease in the number and size of retinal ganglion cells of C57BL/6J le rd mutants. Biochemical assays of control and rd/rd mice (C3H/HE-N-CRJ strain) have revealed striking increases in the GABA content and GAD activity in rd/rd mice (Murashima et al., 1990) .
There is probably an interaction between the two inhibitory systems in the CNS. Upregulation of GABA receptors has been reported in other areas of the CNS of the spastic mutant mouse (White & Heller, 1982) . We studied the retinal GABA system in the hybrid B6C3F3 mice carrying the spastic mutation and found reductions in GABA-immunoreactivity (IR) in the inner retina. This leaves open the possibility that functional abnormalities of spastic mutant retinas may result, in part, from abnormal function of the GABAergic system in addition to the expected abnormalities due the reduced function of the glycinergic system. We found that the retinal degeneration mutation also affects the GABAergic system, an effect that could be due to the loss of photoreceptors because the same effects were seen in rd/rd mice regardless of the allele at the spastic locus.
METHODS

Subjects
Heterozygous, hybrid breeding pairs of mice (B6C3-spa/+; derived from a cross between B6C3F3 spa~spa and B6C3Fe +/+) were obtained from the Jackson Laboratory (Bar Harbor, ME, U.S.A.). Pups were tested for the spastic phenotype at 3 weeks of age; homozygous spa/ spa pups displayed tremor and increased righting time (White & Heller, 1982) . Control litter-mate mates (___) were used as controls. Members of the C3HFe parent strain all carry the mutant allele at the retinal degeneration (rd) locus (LaVail, 1981) . Since the rd and spa genes are unlinked, one fourth of the animals, including spastic mutant animals had the retinal degeneration phenotype.
Immunochemicals
The following primary antibodies and antisera were used to detect various components of GABAergic function.
GABA antiserum (No. 5), a gift of Dr R. Wenthold, was produced in rabbit against GABA conjugated to bovine serum albumin with glutaraldehyde (Wenthold et al., 1986) . Two polyclonal and one monoclonal antibodies against the GABA biosynthetic enzyme 1-glutamate decarboxylase (GAD) were u,;ed: sheep antirat brain GAD (1440-51) was a provided through the laboratory of Clinical Science, NIMH, under the supervision of Dr I. J. Kopin with Drs W Oertel, D. E. Schmechel and M. Tappaz (Oertel et al., 1981) . Monoclonal antibody specific for GAD-65 (Chang & Gottlieb, 1988 ; GAD-6; 1:100) was obtained from the Developmental Studies Hybridoma Bank (Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, and Department of Biology, University of Iowa, Iowa City. IA, Contract NO1-HD-6-2915). Rabbit polyclonal antisera against GAD-67 (K2; Kaufman et al., 1991) was obtained from Chemicon International and used at a dilution of 1:2000. Rabbit polyclonal antiserum against GABA-transaminase (GABA-T), the GABA degradative enzyme, a gift of Dr J. Y. Wu was produced against mouse brain GABA-T (Lin et al., 1983) . Two monoclonal antibodies against the /~2//~3 subunit of the GABAAR/BZDR/CI-channel complex were used. Monoclonal antibody 62-3G1 (Vitorica et al., 1988) , a gift of Dr A. L. De Blas was used at a concentration of 1:10. Monoclonal antibody BD-17 (Schoch et al., 1984; Richards et al., 1987) , a gift of Dr J. G. Richards of Hoffmann-La Roche, Ltd, was used at a concentration of 1:2. We performed experiments in wh!ich retinas were double-labeled with anti-GAD-1440 and anti-tyrosine hydroxylase (the rate limiting enzyme for dopamine synthesis). We used a rabbit polyclonal antisera against bovine adrenal tyrosine hydroxylase (TH; Eugene Technologies) at a concentration of 1:1000.
Secondary antisera were goat-anti-rabbit conjugated to FITC, goat-anti-mouse conjugated to FITC (BoehringerMannheim) and goat anti-rabbit Texas Red (Vector Laboratories).
Histological preparation
Mice were killed by cervical dislocation. Eyes were enucleated; the cornea and lens were removed. Eyecups were fixed in 2.5% glutaraldehyde plus 2% paraformaldehyde (for GABA-IR) or in 4% paraformaldehyde (for all other primary antisera/antibodies) in 0.1 M phosphate buffer (pH 7.4) for 6 hr, rinsed for 1 hr in rinse buffer (RB: 0.l M phosphate buffer with 5% sucrose and 0.15 mM CaCl2) and transferred to 30% sucrose in phosphate buffer overnight at 4°C for cryoprotection. The eyecups were embedded in a 30%/3% gelatin/egg albumin embedding medium and frozen in isopentane cooled by liquid nitrogen.
Cryostat sections (12 #m thick) were washed in FIGURE 1. GABA-IR (1:6000) in the retinas of control (A), spastic (B), and rd/rd (C) mice. All conditions are characterized lay labeling of numerous cell bodies in the proximal INL, fewer cell bodies in the GCL, and stratification in the IPL. Punctate labeling is also visible in the OPL of control and spastic retinas. Overall, the pattern of GABA-IR in control and spastic retinas is similar, except that the lamination in the mid IPL (25% and 55% levels, arrowheads) appears more prominent in the spastic retina. Major differences are seen with the rd/rd retina (C) in which cell bodies of bipolar cells and M611er cells are labeled, along with Miiller cell processes that extend fi'om the inner limiting membrane to the OPL (arrows). In addition, there are four distinct laminae in the IPL. Calibration bar = 5(} #m.
phosphate-buffered-saline (PBS) for 1 hr and incubated in 2% normal goat serum (NGS) in PBS for 15 min. Sections were incubated in primary antisera/antibodies diluted in PBS with 0.3% Triton X-100 in a humid FIGURE 2. GABA-IR (1:1000) in a control mouse retina to illustrate punctate processes in the OPL (arrowheads). Calibration bar = 20 pro. chamber at 4°C for 60 hr, then washed for 1 hr in PBS, incubated in secondary antisera-FITC for 1 hr at 37°C, washed in PBS and coverslipped. Sections were viewed and photographed on an Olympus BH-2 epifluorescence microscope.
RESULTS
GABA-immunoreactivity
Control mouse. GABA-immunoreactivity [ Fig (B) , and rd/rd (C) mice. Overall, the patterns are very similar with numerous cell bodies in the proximal INL, three major laminae in the IPL and a thin layer of processes in the OPL. Two apparent differences are that the intensity of labeling is less in the OPL of spastic retina (B) and that fascicles of fibers in the optic fiber layer are labeled heavily in the rd/rd retina (C, arrow). Calibration bar = 50/lm. distributed throughout the inner plexiform layer (IPL), with broad bands of label in the distal 25% and proximal 40% of the IPL. There also was indication of two thin bands of increased GABA-IR at about the 25% and 55% levels.
Spastic mutant mouse. GABA-IR in spastic mutant retinas [ Fig. I (B)], appeared very similar to that found in control retinas except that the two thin bands of GABA-IR at the 25% and 55% levels of the IPL appeared more prominent in the spastic mutant. The impression was that the broader bands of label in the proximal and distal IPL of the spastic retina were reduced in density compared to control retinas, thereby enhancing the appearance of the narrow strata. The attenuation of the more proximal band was more pronounced when the dilution of GABA anti sera was increased to 1:12 000 (Fig. 3 ). There was an overall reduction in GABA-IR in both control and spastic mutants. Moreover, the spastic mutant retinas showed very few intensely GABA-IR cells in the GCL and a loss of GABA-IR in the proximal 40% of the IPL, compared to control. 
Retinal degeneration mouse.
GAD-immunoreactivity
There were differences in distribution among the three GAD-antisera but only for GAD-1440 was there one apparent difference between control, spastic, and retinal degeneration mutant retinas. GAD-14,40-IR (Fig. 4) labeled numerous amacrine cell bodies in the proximal third of the INL and at least five laminae throughout the appeared more diffuse than confined to discrete processes, and overall appeared weaker than observed in control and retinal degeneration retinas.
The labeling patterns of anti-GAD-65 (Fig. 6 ) appeared the same for all three phenotypes and had a very similar distribution to GAD-antisera 1440 except that there was no staining in the OPL and the density of label at the 90-100% level in the proximal IPL appeared less intense with anti-GAD-65.
As with anti-GAD-65, anti-GAD-67 did not label the OPL (Fig. 7) . Also, the labeling intensity of anti-GAD-67 was weaker over the amacrine cell bodies. The lamination in the IPL consisted of three broad layers and appeared more diffuse compared to anti-GAD-1440 and anti-GAD-65. A notable difference was that the separa- tion of the three main laminae occurred at the 20% and 50% levels as opposed to the 25% and 5.';% levels for anti-GAD-1440 and anti-GAD-65. The consequence is that the two dense GABA-IR bands in the mid-IPL overlap regions stained with anti-GAD-67 but not anti-GAD-1440 or anti-GAD-65. Also note that the labeling intensity in the most proximal IPL (95%) was comparable for anti-GAD-1440 and anti-GAD-67, both of which were denser in this region than observed with anti-GAD-65.
GABA-T immunoreactivity
GABA-T-IR (Fig. 8) had the same distribution in control, spastic and retinal degeneration mutant mice.
GABA-T-IR was punctate in appearance and extended from the inner limiting membrane to the outer limiting membrane. Punctae appeared arranged in vertical streaks in the INL and outer nuclear layer (ONL). There were three broad laminae in the IPL with narrow darker bands at the 25% and 55% IPL depths. Overall, this pattern of GABA-T-IR suggests localization to Mtiller glial cells.
GABAA receptor f12/f13 subunit immunoreclctivity
Labeling with mAb 62-3G1 (Fig. 9 ) in tile inner retina of control, spastic and retinal degeneration mutant was observed in select cell bodies in the INL and throughout the IPL, in which three laminae at the 25%, 55% and 95% levels were apparent. Two types of amacrine cell body were labeled intensely with mAb 62-3G1 (Fig. 10 ), one type with its soma at the proximal margin of the INL and a second type placed more distally in the INL. Differences among the three genotypes were noted in the outer retina. In control retinas [Figs 9(A) and 10(A)], bipolar cell bodies and their processes ascending to the OPL were stained weakly but they gave rise to brighter punctae in the OPL. Such bright processes in the OPL were far less apparent in spastic retinas [ Fig. 9(B) ]. An oblique section through the outer retina of an rd/rd mouse clearly shows labeling for mAb 62-3G1 over bipolar cells bodies and their processes radiating from the cell body into the OPL [ Fig. 10(C) ]. Labeling with BD-17 (Fig. 11 ) appeared similar to that obtained with mAb 62-3G 1, trilaminar labeling in the IPL (25%, 55%, 95% levels), two types of labeled amacrine cell bodies, and labeled bipolar cell bodies that gave rise to stained processes in the OPL. As with mAb 62-3G1, bipolar cell processes in the OPL appeared stained more intensely in the control and retinal degeneration retinas than in spastic retina [ Fig. l l(B) ]. However, overall, it appeared as if the processes in the OPL were stained more intensely by BD-17 than mAb 62-3G1.
rd/rd mice with spastic phenotype
We found that staining intensity in the OPL of spastic mutants was less than in retinal degeneration mutants for GAD-1440, mAb 62-3G1, and BD-17. ix, question that arose was, would the staining patterns in the OPL of mice, in which both mutations were expressed, resemble the spastic or retinal degeneration single homozygotes?
The answer is illustrated for GAD-1440 and BD-17 in Fig. 12 . Processes in the OPL were stained more intensely in rd/rd mice regardless of whether the mice with retinal degeneration phenotype also had the spastic mutant phenotype. Thus, the consequence of the retinal degeneration mutation appears to override the effect of the spastic mutation in regard to effects on the GABA system.
DISCUSSION
Our findings on the GABA system in the retina of the control mouse are similar to those reported using a variety of GABA markers in the retinas of other rodents, including mouse, rat, guinea pig, and ground squirrel (Agardh et al., 1987; Brandon, 1985; Caruso et al., 1989; Greferath et al., 1993; Mosinger et al., 1986; Osborne et al., 1986; Schnitzer & Rusoff. 1984; Vaughn et al., 1975) . Namely, GABA releasing neurons are likely to be restricted to several subtypes of amacrine cell in both the INL and GCL and a subtype of interplexiform cell with processes in the OPL. We found no evidence to indicate that photoreceptors, horizontal cells or bipolar cells synthesize, contain or degrade GABA. A summary schematic of the distributions of the various GABA markers in the IPL of the three conditions is shown in Fig.  13 .
Control mouse
GABA-IR in the ganglion cell layer. GABA-IR in cells
of the GCL has been observed in the retinas of all mammals so far investigated (i.e. Agardh et al., 1987; Koontz et al., 1993; Mosinger et al., 198(5; W/issle & Chun, 1989) . Most of these cells are displaced amacrine cells that include cholinergic (Brecha et al., 1988; Kosaka et al., 1988; Vaney & Young, 19881 , and, at least in rat and mouse, a very small percentage of dopaminergic amacrine cells (Ballesta et al., 1984; Simon et al., 1989; Wulle & Schnitzer, 1989 the labeled neurons we observed in the GCL of mouse are probably ganglion cells. . The immunocytochemical localization of both molecular forms of GAD, GAD-65, and GAD-67, appear quite similar in that both are restricted to amacrine cells in the INL and are broadly distributed in three laminae in the IPL. However, three differences are noted. First, GAD-65 has a more discretely laminar appearance in the IPL whereas GAD-67 appears more diffuse; second, GAD-67 stains more dense in the most proximal IPL; third, the two proximal bands of GAD-67 are displaced distally about 5% such that the dark borders between the lamina occur at 20% and 50% depths rather than 25% and 55% depths. A differential distribution of GAD-65 and GAD-67 has been noted in cat and monkey retina in which both GAD forms are present in overlapping populations of amacrine cells but only one form (GAD-65 in monkey; GAD-67 in cat) is present in horizontal cells . Also, in cat, GAD-67 appears localized to larger amacrine cells that colocalize other transmitters, whereas GAD-65 appears localized to smaller amacrine cells that may not contain another transmitter (Vardi & Auerbach, 1995) . Recently, Brandon and Criswell (11995) showed that the GABA-containing starburst amacrine cells in rabbit retina contain GAD-67 not GAD-65. This is likely to be the case for mouse as well because the comparative lamination in the IPL (Fig. 13) shows that GAD-65 does not overlap the GABA-IR bands in the mid-IPL (25%, 55% levels), whereas GAD-67 does. Thus, the distal extension of the GAD-67 bands is just enough to overlap the processes of the presumptive starburst amacrine cells. It is clear from the different laminar patterns in the IPL, particularly in the most proximal layer, that GAD-65 and GAD-67 are expressed in different though overlapping populations of amacrine cells.
GAD-1440. The distribution of GAD 1440 in the IPL appears as a combination of that produced by GAD-65 and GAD-67: the discrete lamination of GAD-65 with the increased staining in the proximal IPL as with GAD-67. This combined pattern is to be expected because the polyclonal GAD-1440 (Oertel et al., 1981) has broad recognition of both molecular forms of GAD, although there is a preference for GAD-65 (Kaufman et at., 1991) . Note that GAD-1440 also does not overlap the GABA-IR bands at the 25% and 55% IPL depths (Fig. 13) . It therefore was very surprising the GAD-1440 labeled processes in the OPL that were not labeled with either
ii FIGURE 13. Schematic illustration of the labeling patterns obtained with the various GABA markers in the IPL of Conrail, spastic and rd/nt mice. Lamination in the IPL is indicated from the INL border (0%) to the GCL border (100%). Antisera include: GABA, GABA-T, GAD-1440, GAD-65, GAD-67, and GABAA receptor antibodies: mAb 62-3G1 and BD-17. A major point is that the increased bands of GABA-IR label at the 25% and 55% levels overlap labeling of GABA-T, GAD-67, mAb 62-3G1 and BDI7 but not labeling of GAD-1440 or GAD-65. The relative labeling intensity has been subjectively illustrated as: weak (stippled), moderate (gray), and intense (black). The horizontal dotted lines through the figure are at the levels of the stratification of starburst amacrine cells in sublaminae (A) and (B).
GAD-65 or GAD-67. This labeling is probably valid because the same processes are labeled for tyrosinehydroxylase; all dopaminergic neurons in mouse retina also label for GABA-IR, (Wulle & Wagner, 1990) , and dopamine neurons in mouse retina include interplexiform cells with processes in the OPL (Ballesta et al., 1984; Wulle & Schnitzer, 1989) . It seems evident that there is an epitope of GAD in mouse IPC processes that is recognized by polyclonal GAD-1440 but not by the more specific GAD-65 or GAD-67 antibodies. The implication is that the combined use of GAD-65 and GAD-67 antibodies does not provide a complete picture of GAD containing neurons in the retina. GABAA receptor f12/f13 subunits. The distribution of two antibodies against the/~2/]33 subunits of the GABAA receptor (mAb 62-3G1 and BD-17) appeared identical in the IPL, but different in the OPL in which BD--17 labeled bipolar cell bodies and dendrites more intensely than mAb 62-3G1. Although both antibodies have been reported to recognize the same epitopes of the /~2//~3 subunits (Ewert et al., 1992) , the labeling patterns in the retina of all species so far investigated are not the same in the outer retina. For example, the OPL of fish retina is labeled only by mAb 62-3G1 (Lin & Yazulla, 1994; Yazulla et al., 1989) . However, the OPL of monkey and cat is not labeled by mAb 62-3G1 (Hughes et. al., 1989 (Hughes et. al., , 1991 ) but the OPL is labeled by BD-17 not only in cat and monkey (Vardi et al., 1992; but also in rat, rabbit and human (Greferath et al., 1994 (Greferath et al., , 1995 . The mouse then is consistent with other mammalian retinas in which the OPL, in this case bipolar cell dendrites, is labeled more intensely with BD-17. Our data showing the presence of GABAA receptor/~2/ /~3 subunits on bipolar cell dendrites supports the electrophysiological data of Suzuki et al. (11990) who showed that GABA induced currents in isolated mouse bipolar cells when GABA was applied to the: dendrites, although the induced current was about 50% less than when GABA was applied to the axon terminal. Diffusion of GABA from the OPL to the IPL could not account for the OPL-induced responses because GABA had a negligible effect when applied to the axon in the IPL even though this position was closer to the axon terminal. Thus, GABAA receptors are present on mouse bipolar cell dendrites and the likely source of endogenous GAB A is the GABA/dopamine interplexiform cell. One curiosity is that GABA-IR in the OPL is sparse and punctate compared to the well-defined processes stained by TH-IR and GAD-1440-IR. We have no explanation for this difference and presume that for some reason, GABA-IR does not indicate the full extent of the GABAergic processes in the OPL.
The glial localization of GABA-T in the mouse is consistent with rat retina and accounts for observations that GABA-IR is not found in Miiller cells unless GABA-T activity is inhibited (Cubells et al., 1988; Neal et al., 1989) .
Differences among genotypes
Four differences were noted among control, spastic and retinal degeneration mice. First, GABA-IR was reduced in the IPL and GCL of spastic mutant retina. Second, GABA-IR was enhanced in the retinal degeneration mutant retina. Third, GAD-1440 was reduced over processes in the OPL of spastic mutant retina.
Fourth, GABAA receptor IR was reduced over bipolar cell dendrites in spastic mutant retinas. The reduction of GAD-1440 and GABAA receptor IR in the OPL of spastic mutants did not occur in mice that also carried the retinal degeneration mutation.
Control vs spastic mouse
GABA-IR. The appearance of GABA-IR in control and spastic mutant retinas appeared very similar at dilutions of GABA antisera from 1:1000 to 1:6000. However at higher dilutions, in spastic retinas, there was a relative reduction in the number of GABA-IR cells in the GCL and the prominent appearance of a narrow strata in the proximal IPL. Two narrow strata, one each just distal and proximal to the mid region of the IPL, resembled what one would expect for starburst amacrine cells, cholinergic amacrine cells that have been shown to colocalize GABA in the retinas of rabbit and rat (Brecha et al., 1988; Kosaka et al., 1988; Vaney & Young, 1988) . In this regard it is expected that mouse retina would contain starburst amacrine cells that also contained GABA. Of greater interest is the reason for the decrease in GABA-IR in the proximal retina of spastic mice that made the bilamination in the IPL so prominent compared to control. It appears that the relative reduction in GABA-IR of spastic retinas was restricted to the most proximal IPL and cells in the GCL. However, there was no apparent change in the distribution of GAD, GABA-T or GABAA receptors in the proximal IPL of spastic retinas.
Thus, the reduction in GABA-IR levels should not be due to the loss of GABA synthesizing or receptive neurons. One alternative is that GABA-containing ganglion cells lost their ability to take up and subsequently store GABA. Both [3H]GABA uptake and expression o:f the GAT-1 GABA transporter have been localized to numerous cells in the mouse and rat GCL, and at least in rat ~,;ome of these have been shown to include ganglion cells (Blanks & Roffler-Tarlov, 1982; Brecha & Weigmann, 1994; Ruiz et al., 1994) . Also, whole cell recordings from dissociated ganglion cells in immature mice (postnw~al day 1-6) showed that some ganglion cells responded with an increased frequency of spontaneous synaptiLc currents to applied GABA, indicative of some depolari~'ing action of GABA (Bahring et al., 1994) . High affinity GABA uptake is electrogenic (Malchow & Ripps, 1990) and it is possible that GABA uptake by a population of ganglion cells could modulate sensitivity of these cells. If so, then the spastic mouse may have a defect in GABA uptake in ganglion cells and this could affect the sensitivity or responsivity to light.
GABAA receptor ~2/~3 subunits. Both mAb 62-3G1
and BD-17 showed reduced labeling over' bipolar cell processes in the OPL of spastic mutants that did not have the retinal degeneration phenotype compared to control and rd/rd retinas. One possibility was a down regulation of GABA receptors in response to increased GABA release by interplexiform processes in the OPL. Although there was an overall reduction in GABA-IR levels in the inner retina of spastic mice, we found no indication of an increase or decrease in GABA-IR labeling in the OPL of spastic mutant mice and only a small decrease in GAD-1440 in the spastic OPL. Curiously, the amount of GABA-IR in the OPL was not comparable to what would be expected given the level of GAD-1440 and GABAreceptor IRs. Spastic mutant mice have retinal ganglion cells with abnormal receptive field organization: in mutant retinas, an annular stimulus does not elicit a response that is characteristic of the surround mechanism; whereas in control mice, an annular stimulus always evokes a surround response from cells with concentric centersurround organization. However, illumination of the receptive field periphery attenuates the center-type responses evoked from both spastic mutant and control retinas (Stone & Pinto, 1992) . The finding that glycine receptor density was reduced in the IPL, but not the OPL, suggested that the surround responses were mediated by glycinergic synapses in the IPL and surround antagonism was mediated by glycinergic synapses in the OPL . However, the present results suggest an alternative or complementary possibility: the inability to evoke surround-type responses may result from a deficit of GABA neurotransmitter in the IPL or GABAA receptors in the OPL.
Control vs retinal degeneration mutant mouse
Aside from the loss of photoreceptors and their synaptic contacts in the OPL (i.e. Sonohara & Shiose, 1968; Caley et al., 1972; Blanks et al., 1974) little other changes in retinal histology have been noted in rdlrd mice (Grafstein et al., 1972) . However, biochemical studies have shown alterations in dopamine metabolism (Nir & Iuvone, 1994) of rds mice; although no changes in dopamine neurons were detected using histofluorescence techniques in the dystrophic C3H mouse (Kato et al., 1981) . Duvoisin et al. (1995) reported changes in the expression of glutamate receptor subunits in rdlrd mouse: KA-1 was reduced, GluR7 was increased and seven other subunits were unchanged. There also appear to be significant differences in the GABA system of rdlrd mice (Murashima et al., 1990) .
GABA-IR. As determined by GABA-IR, we found a large increase in the GABA content of rd/rd retinas. This increase could be accounted for largely by Mtiller cells that were labeled heavily from their end feet to the OPL. Numerous cell bodies in the mid INL were labeled with GABA-IR as well which seemed to include bipolar cells. The dense band of GABA-IR that appeared at the distal border of the IPL in rdlrd retinas could to be due to MiJller cell processes because a similar band is labeled by GABA-T, an enzyme restricted mostly to Mialler cells (see Fig. 9 ). However, at a 1:12000 dilution of GABA antisera, the Mtiller cell labeling was reduced markedly, while the thin band of GABA-IR in the distal IPL is still quite visible. Ordinarily GABA-IR is virtually undetectable in MUller cells of control mouse retina or in rat retina unless GABA-T activity is inhibited (Cubells et al., 1988; Neal et al., 1989) . Alternatively, this distal band as well as the broader labeling at the 25% and 55% levels could be due to processes of cone bipolar cell types. Recently, in rat retina, Euler and W~ssle (1995) described cone bipolar cells with cell bodies in the mid INL and monostratified at the most distal and mid IPL levels, similar to the additional GABA-IR labeling seen in the rd/rd mouse. It is likely that both Mtiller cells and bipolar cells contribute to the additional GABA-IR in the rd/rd mouse retina.
Biochemical assays of control (C57BL) and dystrophic (C3H) mice showed a significant increase in retinal GABA content (twofold) and GAD activity (fourfold) in the rdlrd mouse (Murashima et al., 199011 . However, no differences in glutamate levels and only sraall intraretinal differences in GABA-T activity were noted. Our data support the biochemical data regarding GABA content and localize the increase to MUller and bipolar cells. However, we noted no obvious difference in GAD-IR staining. Isolated mouse Miiller cells take up [3H]GABA (Sarthy, 1982) , and in the absence of any apparent change in GABA-T levels, the M[iller cells appear to accumulate excess GABA released presumably from amacrine cells. The role of the increased GABA is unclear. Murashima et al. (1990) reported that, unlike control waice, light-and dark-adapted retinas of dystrophic C3H mice had the same levels of GABA and GAD, and they suggested that the excess GABA was formed in response to photoreceptor degeneration. This suggestion was based on the hypothesis that GABA serves as a trophic factor in retinal development as well as a neurotransmitter (Madtes & Redburn, 1983; Wolfe, 1981) .
GABAA receptor ~2/~3 subunits. Bipolar cell dendrites of rdlrd mice also showed increased levels of staining for the/~2//~3 subunits of the GABAA receptor, particularly for antibody mAb 62-3G1. The increased staining of rd! rd retinas was less marked for BD-17, which stained the OPL more than mAb 62-3G1, even in control retinas. This increased staining of bipolar cells was unique to the retinal degeneration mutation condition regardless of whether the mice displayed the spastic phenotype. As yet we are unaware of any anatomical studies regarding the development of GABA receptors in mammalian retina. It is possible that the increase in GABAA receptor staining is related to the increased GABA levels as part of a general response to photoreceptor degeneration.
Concluding remarks
The use of mutant animals to study complex physiological processes has been productive in testing hypotheses generated by other types of experiments and to identify novel genes involved in these processes (see Takahashi et al., 1994 for review). It is tempting to assume that when a genetic lesion is made which affects a specific gene product, the physiological consequences result from an alteration in the altered gene product. However, many results from gene knockout experiments show that little or no alteration in phenotype results from the ablation of a gene thought to be involved in a process. Our results with the spastic mutant mouse demonstrate that attenuation in the glycinergic system is accompanied by a decrease in the GABA system, giving added reason for caution in the interpretation of experiments involving genetic manipulation of complex phenotypes. This is illustrated further by our observations that the reduced labeling of GAD-1440, mAb 62-3G1, and BD-17 in the OPL of spastic mutants only occurs if the spastic mutants do not also express the retinal degeneration mutation. We infer from this that the consequence of retinal degeneration on GABA function in the OPL offsets whatever compensatory effect the spastic mutation has on the GABA system.
